Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 6/20 | 0.33 |
| ▸ | SPHK2 | Q9NRA0 | 5/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1038492 | 0.86 | SPHK1 (0.36) | SPHK1SPHK2ALDH1A1 | |
| SCHEMBL23646739 | 0.79 | SPHK1 (0.33) | SPHK1SPHK2ALDH1A1 | |
| SCHEMBL3376087 | 0.79 | SPHK1 (0.37) | SPHK1SPHK2ALDH1A1 | |
| SCHEMBL9803652 | 0.78 | — | — | |
| SCHEMBL28206089 | 0.74 | — | — | |
| SCHEMBL1602822 | 0.69 | — | — | |
| SCHEMBL28145832 | 0.69 | — | — | |
| SCHEMBL11584789 | 0.69 | — | — | |
| SCHEMBL25788720 | 0.68 | — | — | |
| SCHEMBL27906603 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1876211-B1 | Ink composition, inkjet recording method, printed material, method of producing planographic printing plate, and planographic printing plate | FUJIFILM CORP (JP) | 2016-10-19 | — | — | EP | disclosed |
| US-7992988-B2 | Ink composition, inkjet recording method, printed material, method of producing planographic printing plate, and planographic printing plate | FUJIFILM CORPORATION (JP) | 2011-08-09 | — | — | US | disclosed |
| EP-1829684-B1 | Curable composition, ink composition, inkjet-recording method, and planographic printing plate | FUJIFILM CORP (JP) | 2011-01-26 | — | — | EP | disclosed |
| US-7683104-B2 | Curable composition, ink composition, inkjet-recording method, and planographic printing plate | FUJIFILM CORPORATION (JP) | 2010-03-23 | — | — | US | disclosed |
| US-20090233198-A1 | PHOTOCURABLE COMPOSITION, OVERPRINT, AND PRODUCTION PROCESS THEREFOR | FUJIFILM CORPORATION (JP) | 2009-09-17 | — | — | US | disclosed |
| US-20080008943-A1 | INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, METHOD OF PRODUCING PLANOGRAPHIC PRINTING PLATE, AND PLANOGRAPHIC PRINTING PLATE | FUJIFILM CORPORATION (JP) | 2008-01-10 | — | — | US | disclosed |
| EP-1876211-A1 | Ink composition, inkjet recording method, printed material, method of producing planographic printing plate, and planographic printing plate | FUJIFILM Corporation (JP) | 2008-01-09 | — | — | EP | disclosed |
| US-20070206054-A1 | Curable composition, ink composition, inkjet-recording method, and planographic printing plate | FUJIFILM CORPORATION (JP) | 2007-09-06 | — | — | US | disclosed |
| EP-1829684-A1 | Curable composition, ink composition, inkjet-recording method, and planographic printing plate | FUJIFILM Corporation (JP) | 2007-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080008943-A1 | INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, METHOD OF PRODUCING PLANOGRAPHIC PRINTING PLATE, AND PLANOGRAPHIC PRINTING PLATE | PARG, BMP2, PIK3C3 | SPHK1 4424/4885SPHK2 4170/4885ALDH1A1 2035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.